Phase I Study Of Abiraterone Acetate (Aa) In Patients (Pts) With Estrogen Receptor-(Er) Or Androgen Receptor (Ar)-Positive Advanced Breast Carcinoma Resistant To Standard Endocrine Therapies.
JOURNAL OF CLINICAL ONCOLOGY（2011）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要